Small-cell bronchogenic carcinoma. The new stage I;Carcinoma broncogénico no anaplásico de células pequeñas. El nuevo estadio I

Archivos de Bronconeumologia

Volumn 36, Issue 2, 2000, Pages 68-72

  Padilla, J ^a   Penalver J C ^a   Calvo, V ^a   Garcia Zarza A ^a   Pastor, J ^a   Blasco, E ^a   Paris F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bronchogenic carcinoma; Stage I; Surgery

Indexed keywords

ARTICLE; CANCER STAGING; FEMALE; HUMAN; LUNG CARCINOMA; LUNG RESECTION; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SMALL CELL CARCINOMA; SPAIN; SURVIVAL;

CARCINOMA, BRONCHOGENIC; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; SPAIN; SURVIVAL ANALYSIS;

EID: 0345903560     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30210-6     Document Type: Article

References (21)

1. Mountain CF. Revision in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
2. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol 1998; 34: 437-452.
3. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89: S225-S233.
4. Read RC, Schaffe R, North L, Walls R. Diameter, cell type and survival in stage I primary non-small cell lung cancer. Arch Surg 1988; 123: 446-449.
5. Shimizu J, Watanabe Y, Oda M, Hayashi Y, Ota Y, Morita K et al. Results of surgical treatment of stage 1 lung cancer. J Jpn Surg Soc 1993; 94: 505-510.
6. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based of the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 440-447.
7. Roeslin N, Chalkiadakis G, Dumont P, Witz JP. A better prognostic value from a modification of lung cancer staging. J Thorac Cardiovasc Surg 1987; 94: 504-509.
8. Schirren J, Krysa S, Trainer S, Drings P, Vogt-Moykopf I. Surgical treatment and results. Eur Respir Monogr 1995; 1: 210-240.
9. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW et al. Incidence of local recurrence and second primary tumor in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995; 109: 120-129.
10. Padilla Alarcón J, Blasco Armengod E, Borro Maté JM, Galán Gil G, París Romeu F. Factores pronósticos y supervivencia en el tratamiento quirúrgico del carcinoma broncopulmonar no anaplásico de células pequeñas en estadio I. Arch Bronconeumol 1993; 29: 3-6.
11. Padilla J, Calvo V, Peñalver JC, Sales G, Morcillo A. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 1997; 63: 324-326.
12. Watanabe Y, Shimizu N, Oda M, Iwa T, Takashima T, Kamimura R et al. Early lung cancer: its clinical aspect. J Surg Oncol 1991; 48: 75-80.
13. Ichinose Y, Hara N, Ohta M, Jano T, Maeda K, Asoh H et al. Is T factor of the TNM staging system a predominat prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg 1993; 106: 90-94.
14. Harpole DH, Herndon JE, Young WG, Wolfe WG, Sabiston DC. Stage I non-small cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995; 76: 787-796.
15. Read RC, Yoder G, Schafer RC. Survival after conservative resection for T1N0M0 non-small cell lung cancer. Ann Thorac Surg 1990; 49: 391-400.
16. Thomas PA, Piantadosi S, for the Lung Cancer Study Group. Postoperative T1N0 non-small cell lung cancer. Squamous versus non-squamous recurrence. J Thorac Cardiovasc Surg 1987; 94: 349-354.
17. Ichinose Y, Yano T, Asoh H, Yokoyama H, Yoshino I, Katsuda Y. Prognostic factors obteined by examination in completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg 1995; 110: 601-605.
18. Sánchez de Cos Escín J. Tratamiento actual del carcinoma bronco-pulmonar no microcítico y nueva clasificación TNM. Arch Bronconeumol 1999; 35: 91-93.
19. Splinter TAW. Paclitaxel and carboplatin as neoadyuvant chemotherapy in operable (stage I and II) and locally advanced (Stage IIIA-N2) non-small cell lung cancer. Semin Oncol 1996; 16: 59-61.
20. Bülzebruck H, Bopp R, Drigs P, Bauer E, Krysa S, Prosbt G. New aspects in the staging lung cancer. Prospective validation of the International Union Against Cancer TNM classification. Cancer 1992; 70: 1102-1110.
21. Sanz GF, Sanz MA, Greenberg PL. Prognostic factors and scoring system in myeldysplastic syndromes. Haematologica 1998; 83: 358-368.